Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Themis Medicare Ltd. is a pharmaceutical company engaged in the development, manufacturing, and marketing of a diverse range of therapeutic products. Its primary function is to deliver high-quality medicines across various segments such as anti-tuberculosis, anti-malarial, cardiology, and pain management medications. Themis Medicare is notably involved in the formulation of biotechnology-based pharmaceuticals, emphasizing the development of innovative healthcare solutions to address unmet needs. The company influences industries involved in health, wellness, and medical therapies, contributing significantly to public health outcomes. Headquartered in India, Themis Medicare operates with a global outreach, serving markets across Asia, Europe, and Africa. Its strategic focus on research and development positions it as a crucial player in the pharmaceutical sector, advancing medical therapies and patient care globally.